← All trials
NCT05076604
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 25, 2019
- Primary completion
- Dec 31, 2021
- Completion date
- Feb 15, 2022
- First posted
- Oct 13, 2021
- Last posted
- Oct 13, 2021
- Enrollment
- 314
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Washington University in St. LouisLead sponsor
- Washington University in St. LouisOverall official - principal investigator
- Quest DiagnosticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.